Simulations Plus Inc
Save
857.99M
Market cap
81.08x
Current P/E
64.10x
Forward P/E
About
Health care
Sector
Healthcare - Information Services
Industry
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Similar securities
Based on sector and market capitalization
Report issue